Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Previous studies have shown that systemic, but not unilateral intra-prefrontal cortex administration of non-competitive NMDA antagonists, increased prefrontal activity, the cortical efflux of serotonin, and induced stereotypies. In this work we used in-vivo microdialysis and immunohistochemistry to test the hypothesis as to whether MK-801 and ketamine need to act on both prefrontal cortices to reproduce these neurochemical and behavioural changes. Dialysis probes were implanted in the medial prefrontal cortex, and extracellular serotonin as well as behavioural stereotypies was measured after systemic administration of MK-801 and ketamine (1 mg/kg and 25 mg/kg, respectively), and unilateral and bilateral perfusion of both drugs (300 μm and 3 mm, respectively). Additionally, the prefrontal (glutamatergic) level of activity was measured using c-Fos immunohistochemistry. Systemic and bilateral (but not unilateral) prefrontal administration of MK-801 and ketamine increased serotonin efflux whereas only systemic administration of both drugs produced hyperlocomotion and stereotypies. The unilateral perfusion of 1 μm tetrodotoxin in the medial prefrontal cortex reduced increases of serotonin in both hemispheres, the expression of c-Fos in the contralateral side, and stereotypy scores after systemic NMDA antagonists. Our results support the hypothesis that a bilateral impairment of cortical inhibition in the medial prefrontal cortex is needed for non-competitive NMDA antagonists to induce the state of pyramidal cell hyperactivity and concurrent efflux of serotonin. Furthermore, hyperlocomotion and stereotypies produced by MK-801 and ketamine do not appear to result from changes in the activity of prefrontal cortex although this structure exerts some control over these behaviours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 6×
“Doses and perfused concentrations of MK-801 and ketamine were selected from previous studies (López-Gil et al. 2007; Moghaddam et al. 1997), taking into consideration their different affinity for the NMDA channel site (Murray et al. 2000).”
InfluentialGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 1×
“…GABAergic inhibition of pyramidal cells, thus leading to a disinhibited state of pyramidal activity (Krystal et al. 2003; Moghaddam et al. 1997; Olney & Farber, 1995), which is associated with excessive neuronal activity and efflux of glutamate and 5-HT within the mPFC (Adams & Moghaddam,…”
The use of c-fos as a metabolic marker in neuronal pathway tracing
Dragunow, M., & Faull, R. (1989) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(89)90150-7 · Cited by 1,416 · cited 2×
“A highly active serotonergic transmission has been implicated in schizophrenia (Meltzer, 1989) and in the hyperlocomotion induced by the ablation of the NR2A subunit of NMDA receptors (Miyamoto et al. 2001).”
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“Recent data (Homayoun & Moghaddam, 2007) and the present study further suggest that these inhibitory neurons are located within the mPFC.”
Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers
Gabbott, P. L. A., Warner, T. A., Jays, P. R. L., Salway, P., & Busby, S. J. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20738 · Cited by 1,227 · cited 3×
“The increase of 5-HT concentration most likely results from the elevation of the excitatory output of a subpopulation of pyramidal neurons in layer V of mPFC that project heavily to the DR (Gabbott et al. 2005) and tightly control the activity of 5-HT cells (Celada et al. 2001; Hajós et al. 1998).”
Working memory dysfunction in schizophrenia
(1994) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.6.4.348 · Cited by 1,068
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 1×
“…microdialysis, unilateral intra-mPFC perfusion of noncompetitive NMDA antagonists failed to replicate the effects of their systemic administration (Aghajanian & Marek, 2000 ; López-Gil et al. 2007; Lorrain et al. 2003; Suzuki et al. 2002), which would suggest an extracortical site(s) of action.”
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497 · cited 4×
“The increase of 5-HT concentration most likely results from the elevation of the excitatory output of a subpopulation of pyramidal neurons in layer V of mPFC that project heavily to the DR (Gabbott et al. 2005) and tightly control the activity of 5-HT cells (Celada et al. 2001; Hajós et al. 1998).”
InfluentialSelf-citation
Cited by
Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
“) and intra-mPFC (3 mM) routes of administration, an increase in 5-HText was described in the mPFC (Lopez-Gil et al., 2012).”
BackgroundFukumoto, K., Iijima, M., & Chaki, S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.233 · Cited by 174
Pham, T. H., Mendez-David, I., Defaix, C., Guiard, B. P., Tritschler, L., David, D. J., & Gardier, A. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.010 · Cited by 136
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
López-Gil, X., Jiménez-Sánchez, L., Campa, L., Castro, E., Frago, C., & Adell, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00288 · Cited by 80
Self-citationEl Iskandrani, K. S., Oosterhof, C. A., El Mansari, M., & Blier, P. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573809 · Cited by 75
“While this result indicates an involvement of the mPFC, it did not show a greater activation in DRN following NMDA receptor blockade (Lopez-Gil et al., 2011), which is concordant with results obtained herein on the firing activity of 5-HT neurons.”
Result
Metadata
- Authors
- López-Gil, X., Jiménez-Sánchez, L., Romón, T., Campa, L., Artigas, F., & Adell, A.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07-07
- Volume
- 15
- Issue
- 07
- Pages
- 945-956
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2112435636
- Cited by
- 33
- References
- 12
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. https://app.cochat.ai/papers/10.1017/s1461145711001064
- The paper
- López-Gil, X., Jiménez-Sánchez, L., Romón, T., Campa, L., Artigas, F., & Adell, A. (2012). Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145711001064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.